Sep 9, 2025 · Redwood City — To provide more flexible treatment options for opioid use disorder among incarcerated persons, San Mateo County Health’s Correctional Health Services has adopted Brixadi, …

Brixadi is the only injectable buprenorphine studied against the standard of care (SL BPN/NX), with no opioid overdoses in patients receiving Brixadi during clinical trials. 23 The safety profile of Brixadi …

Aug 22, 2025 · This literature review examines the comparative effectiveness of long-acting injectable (LAI) medications—such as Sublocade, Brixadi, and Vivitrol—versus oral formulations for treating …

Learn about opioid addiction, or opioid use disorder (OUD), how it affects the brain, and how BRIXADI may help. Please see Prescribing Information, including Boxed Warning, and Medication Guide.

We also provide medication-assisted treatment for alcohol withdrawal and relapse prevention. Ideal Option providers in Great Falls may prescribe a variety of medications, including Suboxone®, …

Apr 16, 2024 · Some buprenorphine formulations contain naloxone to prevent relapse. Does Brixadi have naloxone in it? Here’s a complete Brixadi drug analysis.

The U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use to treat moderate to severe opioid use disorder (OUD)

Mar 15, 2024 · Buprenorphine extended-release (ER) injection for subcutaneous use (Brixadi®; CAM2038; hereafter referred to as buprenorphine ER) is a useful addition to the treatment options …

What We Offer Evidence-based treatment including CBT, Motivational Interviewing, and mindfulness- based treatment Medication Assisted Treatment (MAT) education and maintenance of Brixadi®, …

Apr 18, 2025 · This makes long-acting treatments particularly well-suited to the maintenance phase, where long-term abstinence and relapse prevention are critical for long-term recovery. Long-acting …